The most useful laboratory test for hepatoblastoma is alpha-fetoprotein (AFP), showing abnormal elevation in 80–90% of patients, and therefore serving as a sustainable biomarker for diagnosis, monitoring, and disease follow-up [1]. This evidence concerns the gene AFP and hepatoblastoma.